91制片厂

91制片厂 Reports Fourth Quarter and Fiscal Year 2020 Financial Results

News | Feb 11, 2021

Fourth Quarter 2020 Highlights:

  • Revenues of $138.9 million, compared with $113.2 million in the same period last year
  • GAAP net loss of $0.1 million, or $(0.00) per diluted share, compared with a loss of $32.9 million, or $0.69 loss per diluted share in the same period last year
  • Non-GAAP net income of $15.0 million, or $0.30 per diluted share, compared with $5.4 million, or $0.11 per diluted share in the same period last year

PLAINVIEW, N.Y., Feb. 11, 2021 (GLOBE NEWSWIRE) — 91制片厂. (Nasdaq: VECO) today announced financial results for its fourth quarter and fiscal year ended December 31, 2020. Results are reported in accordance with U.S. generally accepted accounting principles (鈥淕AAP鈥) and are also reported adjusting for certain items (鈥淣on-GAAP鈥). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.

U.S. Dollars in millions, except per share data
4th Quarter Full Year
GAAP听Results Q4 ’20 Q4 ’19 2020 听听听 2019
Revenue $ 138.9 $ 113.2 $ 454.2 $ 419.3
Net income (loss) $ (0.1 ) $ (32.9 ) $ (8.4 ) $ (78.7 )
Diluted earnings (loss) per share $ (0.00 ) $ (0.69 ) $ (0.17 ) $ (1.66 )

4th Quarter Full Year
Non-GAAP听Results Q4 ’20 Q4 ’19 2020 2019
Net income (loss) $ 15.0 $ 5.4 $ 42.3 $ (1.3 )
Operating income (loss) $ 17.6 $ 7.4 $ 52.5 $ 5.1
Diluted earnings (loss) per share $ 0.30 $ 0.11 $ 0.86 $ (0.03 )

鈥淥ur year-over-year financial performance dramatically improved in 2020 and we are proud to conclude this remarkable year of transformation by delivering solid fourth quarter results. These fourth quarter results were driven primarily by system sales in support of semiconductor advanced-node manufacturing, as well as compound semiconductor system sales for 5G RF applications,鈥 commented William J. Miller, Ph.D., Chief Executive Officer.

鈥淲e enter 2021 with healthy backlog, strong customer engagements and overall positive momentum. We look forward to executing our near-term growth strategy driven in large part by our Laser Annealing, 5G RF and Data Storage applications.鈥

Guidance and Outlook

The following guidance is provided for 91制片厂鈥檚 first quarter 2021:

  • Revenue is expected in the range of $115 million to $135 million
  • GAAP diluted earnings (loss) per share are expected in the range of $(0.09) to $0.09
  • Non-GAAP diluted earnings per share are expected in the range of $0.12 to $0.30

Please refer to the tables at the end of this press release for further details.

Conference Call Information

A conference call reviewing these results has been scheduled for today, February 11, 2021 starting at 5:00pm ET. To join the call, dial 1-866-248-8441 (toll free) or 1-929-477-0577 and use passcode 7940308. Participants may also access a live webcast of the call by visiting the investor relations section of 91制片厂’s website at ir.veeco.com. A replay of the webcast will be made available on the 91制片厂 website that evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

About 91制片厂

91制片厂 (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD, and single wafer etch & clean technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, 91制片厂 holds leading technology positions in the markets we serve. To learn more about 91制片厂鈥檚 systems and service offerings, visit .

Forward-looking Statements

This press release contains 鈥渇orward-looking statements鈥, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, that are based on management鈥檚 expectations, estimates, projections and assumptions. Words such as 鈥渆xpects,鈥 鈥渁nticipates,鈥 鈥減lans,鈥 鈥渂elieves,鈥 鈥渟cheduled,鈥 鈥渆stimates鈥 and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, industry outlooks and demand drivers, our investment and growth strategies, our development of new products and technologies, our business outlook for current and future periods, the impact of the COVID-19 pandemic, our ongoing transformation initiative and the effects thereof on our operations and financial results; and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: the level of demand for our products; global economic and industry conditions; the effects of regional or global health epidemics, including the effects of the COVID-19 pandemic on the 91制片厂鈥檚 operations and on those of our customers and suppliers; global trade issues, including the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; our dependency on third-party suppliers and outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; our ability to obtain and protect intellectual property rights in key technologies; our ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees; the variability of results among products and end-markets, and our ability to accurately forecast future results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings on Forms 10-K, 10-Q and 8-K, and from time-to-time in our other SEC reports. All forward-looking statements speak only to management鈥檚 expectations, estimates, projections and assumptions as of the date of this press release or, in the case of any document referenced herein or incorporated by reference, the date of that document. The 91制片厂 does not undertake any obligation to update or publicly revise any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

91制片厂 Contacts:
Investors: Anthony Bencivenga (516) 252-1438 abencivenga@veeco.com
Media: Kevin Long (516) 714-3978听 klong@veeco.com


91制片厂 Instruments听Inc. and Subsidiaries

Condensed Consolidated Statements of Operations
(in thousands, except per share amounts)
(unaudited)

Three months ended December听31, Year ended December听31,
听听听听 2020 听听听听 2019 听听听听 2020 听听听听 2019
Net sales $ 138,946 $ 113,202 $ 454,163 $ 419,349
Cost of sales 82,101 68,232 259,863 261,155
Gross profit 56,845 44,970 194,300 158,194
Operating expenses, net:
Research and development 21,417 21,655 78,994 90,557
Selling, general, and administrative 20,710 19,128 76,251 79,749
Amortization of intangible assets 3,831 4,312 15,333 17,085
Restructuring 2,529 1,097 6,403
Asset impairment 4,020 281 4,020
Other operating expense (income), net 281 190 (221 ) (42 )
Total operating expenses, net 46,239 51,834 171,735 197,772
Operating income (loss) 10,606 (6,864 ) 22,565 (39,578 )
Interest expense, net (6,516 ) (4,663 ) (23,188 ) (17,405 )
Other income (expense), net (4,794 ) (20,973 ) (7,841 ) (20,973 )
Income (loss) before income taxes (704 ) (32,500 ) (8,464 ) (77,956 )
Income tax expense (benefit) (602 ) 371 (73 ) 777
Net income (loss) $ (102 ) $ (32,871 ) $ (8,391 ) $ (78,733 )
Income (loss) per common share:
Basic $ (0.00 ) $ (0.69 ) $ (0.17 ) $ (1.66 )
Diluted $ (0.00 ) $ (0.69 ) $ (0.17 ) $ (1.66 )
Weighted average number of shares:
Basic 48,340 47,519 48,362 47,482
Diluted 48,340 47,519 48,362 47,482


91制片厂 Instruments听Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in thousands)

December听31, December听31,
听听听听 2020 听听听听 2019
(unaudited)
Assets
Current assets:
Cash and cash equivalents $ 129,625 $ 129,294
Restricted cash 658 657
Short-term investments 189,771 115,252
Accounts receivable, net 79,991 45,666
Contract assets 21,246 25,351
Inventories 145,906 133,067
Deferred cost of sales 433 445
Prepaid expenses and other current assets 19,301 14,966
Assets held for sale 11,180
Total current assets 586,931 475,878
Property, plant and equipment, net 65,271 75,711
Operating lease right-of-use assets 10,275 14,453
Intangible assets, net 46,185 61,518
Goodwill 181,943 181,943
Deferred income taxes 1,440 1,549
Other assets 6,019 7,036
Total assets $ 898,064 $ 818,088
Liabilities and stockholders鈥 equity
Current liabilities:
Accounts payable $ 33,656 $ 21,281
Accrued expenses and other current liabilities 44,876 41,243
Customer deposits and deferred revenue 67,235 54,870
Income taxes payable 914 830
Total current liabilities 146,681 118,224
Deferred income taxes 5,240 5,648
Long-term debt 321,115 300,068
Operating lease long-term liabilities 6,305 10,300
Other liabilities 10,349 9,336
Total liabilities 489,690 443,576
Total stockholders鈥 equity 408,374 374,512
Total liabilities and stockholders鈥 equity $ 898,064 $ 818,088


91制片厂 Instruments听Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in thousands, except per share amounts)
(unaudited)

Non-GAAP听Adjustments
Share-Based
Three months ended December听31, 2020 听听听听 GAAP 听听听听 Compensation 听听听听 Amortization 听听听听 Other 听听听听 Non-GAAP
Net sales $ 138,946 $ 138,946
Gross profit 56,845 486 20 57,351
Gross margin 40.9 %听 41.3 %
Operating expenses 46,239 (2,656 ) (3,831 ) (41 ) 39,711
Operating income (loss) 10,606 3,142 3,831 61 ^ 17,640
Net income (loss) (102 ) 3,142 3,831 8,085 ^ 14,956
Income (loss) per common share:
Basic $ (0.00 ) $ 0.31
Diluted (0.00 ) 0.30
Weighted average number of shares:
Basic 48,340 48,340
Diluted 48,340 49,663
^听听听– See table below for additional details.

91制片厂 Instruments听Inc. and Subsidiaries
Other Non-GAAP Adjustments
(in thousands)
(unaudited)

Three months ended December听31, 2020 听听听听
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting $ 61
Subtotal 61
Non-cash interest expense 3,511
Loss on extinguishment of debt 4,794
Non-GAAP tax adjustment * (281 )
Total Other $ 8,085
*听听听– The 鈥榳ith or without鈥 method is utilized to determine the income tax effect of all Non-GAAP adjustments.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (鈥淕AAP鈥). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors鈥 operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

91制片厂 Instruments听Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in thousands, except per share amounts)
(unaudited)

Non-GAAP听Adjustments
Share-based
Three months ended December听31, 2019 听听听听 GAAP 听听听听 Compensation 听听听听 Amortization 听听听听 Other 听听听听 Non-GAAP
Net sales $ 113,202 $ 113,202
Gross profit 44,970 455 29 45,454
Gross margin 39.7 %听 听听 40.2 %
Operating expenses 51,834 (3,287 ) (4,312 ) (6,213 ) 38,022
Operating income (loss) (6,864 ) 3,742 4,312 6,242 ^ 7,432
Net income (loss) (32,871 ) 3,742 4,312 30,262 ^ 5,445
Income (loss) per common share:
Basic $ (0.69 ) $ 0.11
Diluted (0.69 ) 0.11
Weighted average number of shares:
Basic 47,519 47,519
Diluted 47,519 48,404
^听听听– See table below for additional details.


91制片厂 Instruments听Inc. and Subsidiaries

Other Non-GAAP Adjustments
(in thousands)
(unaudited)

Three months ended December听31, 2019
Restructuring 听听听听 $ 2,132
Asset impairment 4,020
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting 90
Subtotal 6,242
Non-cash interest expense 3,257
Impairment of equity investments 20,973
Non-GAAP tax adjustment * (210 )
Total Other $ 30,262
*听听听– The 鈥榳ith or without鈥 method is utilized to determine the income tax effect of all Non-GAAP adjustments.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (鈥淕AAP鈥). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors鈥 operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

91制片厂 Instruments听Inc. and Subsidiaries
Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (loss)
(in thousands)
(unaudited)

听听听听 Three months ended 听听听听 Three months ended
December听31, 2020 December听31, 2019
GAAP Net income (loss) $ (102 ) $ (32,871 )
Share-based compensation 3,142 3,742
Amortization 3,831 4,312
Restructuring 2,132
Asset impairment 4,020
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting 61 90
Interest (income) expense, net 6,516 4,663
Impairment of equity investments 20,973
Loss on extinguishment of debt 4,794
Income tax expense (benefit) (602 ) 371
Non-GAAP Operating income (loss) $ 17,640 $ 7,432

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (鈥淕AAP鈥). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors鈥 operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

91制片厂 Instruments听Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in thousands, except per share amounts)
(unaudited)

Non-GAAP听Adjustments
Share-based
For the year ended December听31, 2020 听听听听 GAAP 听听听听 Compensation 听听听听 Amortization 听听听听 Other 听听听听 Non-GAAP
Net sales $ 454,163 $ 454,163
Gross profit 194,300 1,870 348 196,518
Gross margin 42.8 %听 听听 43.3 %
Operating expenses 171,735 (10,833 ) (15,333 ) (1,530 ) 144,039
Operating income (loss) 22,565 12,703 15,333 1,878 ^ 52,479
Net income (loss) (8,391 ) 12,703 15,333 22,684 ^ 42,329
Income (loss) per common share:
Basic $ (0.17 ) $ 0.88
Diluted (0.17 ) 0.86
Weighted average number of shares:
Basic 48,362 48,362
Diluted 48,362 49,309
^听听听– See table below for additional details.


91制片厂. and Subsidiaries

Other Non-GAAP Adjustments
(in thousands)
(unaudited)

For the year ended December听31, 2020 听听听听
Restructuring $ 1,097
Asset impairment 281
Release of inventory fair value step-up associated with the Ultratech purchase accounting 273
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting 227
Subtotal 1,878
Non-cash interest expense 13,792
Loss on extinguishment of debt 7,841
Non-GAAP tax adjustment * (827 )
Total Other $ 22,684
*听听听听– The ‘with or without’ method is utilized to determine the income tax effect of all non-GAAP adjustments.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (鈥淕AAP鈥). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

91制片厂. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in thousands, except per share amounts)
(unaudited)

Non-GAAP听Adjustments
Share-based
For the year ended December听31, 2019 听听听听 GAAP 听听听听 Compensation 听听听听 Amortization 听听听听 Other 听听听听 Non-GAAP
Net sales $ 419,349 $ 419,349
Gross profit 158,194 1,903 1,453 161,550
Gross margin 37.7 %听 听听 38.5 %听
Operating expenses 197,772 (13,367 ) (17,085 ) (10,841 ) 156,479
Operating income (loss) (39,578 ) 15,270 17,085 12,294 ^ 5,071
Net income (loss) (78,733 ) 15,270 17,085 45,102 ^ (1,276 )
Income (loss) per common share:
Basic $ (1.66 ) $ (0.03 )
Diluted (1.66 ) (0.03 )
Weighted average number of shares:
Basic 47,482 47,482
Diluted 47,482 47,482
^听听听– See table below for additional details.


91制片厂. and Subsidiaries
Other Non-GAAP Adjustments
(in thousands)
(unaudited)

For the year ended December听31, 2019
Restructuring 听听听听 $ 6,006
Asset impairment 4,020
Release of inventory fair value step-up associated with the Ultratech purchase accounting 1,270
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting 557
Accelerated depreciation 397
Other 44
Subtotal 12,294
Non-cash interest expense 12,676
Impairment of equity investments 20,973
Non-GAAP tax adjustment * (841 )
Total Other $ 45,102
*听听听听– The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (鈥淕AAP鈥). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating Income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

91制片厂 Instruments听Inc. and Subsidiaries
Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (loss)
(in thousands)
(unaudited)

听听听听 Year ended 听听听听 Year ended
December听31, 2020 December听31, 2019
GAAP Net income (loss) $ (8,391 ) $ (78,733 )
Share-based compensation 12,703 15,270
Amortization 15,333 17,085
Restructuring 1,097 6,006
Asset impairment 281 4,020
Release of inventory fair value step-up associated with the Ultratech purchase accounting 273 1,270
Depreciation of PP&E fair value step-up associated with the Ultratech purchase accounting 227 557
Accelerated depreciation 397
Other 44
Interest (income) expense, net 23,188 17,405
Impairment of equity investment 20,973
Loss on extinguishment of debt 7,841
Income tax expense (benefit) (73 ) 777
Non-GAAP Operating income (loss) $ 52,479 $ 5,071

This table includes financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (鈥淕AAP鈥). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors鈥 operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

91制片厂 Instruments听Inc. and Subsidiaries
Reconciliation of GAAP to Non-GAAP Financial Data
(in millions, except per share amounts)
(unaudited)

Non-GAAP听Adjustments
Guidance for the three months ending Share-based
March 31, 2021 GAAP Compensation Amortization 听听听Other听听听听 Non-GAAP
Net sales 听听听听 $ 115 听听听听 听听听听 $ 135 听听听听 听听听听 听听听听 听听听听 $ 115 听听听听 听听听听 $ 135
Gross profit 47 58 47 58
Gross margin 40 % 42 % 40 % 42 %
Operating expenses 44 46 (3 ) (4 ) 37 39
Operating income (loss) 3 12 3 4 10 19
Net income (loss) $ (4 ) $ 5 3 4 3 $ 6 $ 15
Income (loss) per diluted common share $ (0.09 ) $ 0.09 听听 听听 听听 $ 0.12 $ 0.30
Weighted average number of shares (1) 49 53 50 50
(1)听听听听– The non-GAAP incremental dilutive shares includes the impact of the 91制片厂鈥檚 capped call transaction issued concurrently with our 2027 Notes, and as such, no incremental shares are added to the dilutive share count in periods in which the average stock price per share is below $18.46. The GAAP incremental dilutive shares does not include the impact of the 91制片厂鈥檚 capped call transaction, and as such, incremental shares are added to the dilutive share count in periods in which the average stock price per share is above $13.98, and the 91制片厂 is in a net income position.


91制片厂 Instruments听Inc. and Subsidiaries

Reconciliation of GAAP Net Income (loss) to Non-GAAP Operating Income (Loss)
(in millions)
(unaudited)

Guidance for the three months ending March 31, 2021 听听听听 听听听听 听听听听
GAAP Net income (loss) $ (4 ) $ 5
Share-based compensation 3 3
Amortization 4 4
Interest expense, net 7 7
Non-GAAP Operating income (loss) $ 10 $ 19

Note: Amounts may not calculate precisely due to rounding.

These tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (鈥淕AAP鈥). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors鈥 operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.

Recent Posts

91制片厂 is the industry leader driving HDD manufacturing to new levels of productivity.

Driving Quantum Innovation: 91制片厂鈥檚 Advances in Materials Engineering for the Next Era of Computing

Read more

91制片厂 Books Multi-System Lumina and Spector Orders for Manufacturing Indium-Phosphide (InP) based Optical Components

Read more

91制片厂 Reports Fourth Quarter and Fiscal Year 2025 Financial Results

Read more

91制片厂 Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call

Read more

Our team is ready to help